HB 5051

  • Illinois House Bill
  • 103rd Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Prior Auth-Prescription Drugs

Abstract

Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone.

Bill Sponsors (6)

Votes


No votes to display

Actions


Apr 24, 2024

House

Added Co-Sponsor Rep. Lilian Jiménez

Apr 05, 2024

House

House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

House

Rule 19(a) / Re-referred to Rules Committee

Mar 21, 2024

House

House Committee Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee

Mar 20, 2024

House

House Committee Amendment No. 1 Filed with Clerk by Rep. Jenn Ladisch Douglass

House

House Committee Amendment No. 1 Referred to Rules Committee

Mar 05, 2024

House

Assigned to Health Care Availability & Accessibility Committee

Feb 26, 2024

House

Added Co-Sponsor Rep. Margaret Croke

House

Added Co-Sponsor Rep. Mary Beth Canty

Feb 21, 2024

House

Added Co-Sponsor Rep. Kelly M. Cassidy

House

Added Co-Sponsor Rep. Gregg Johnson

Feb 08, 2024

House

First Reading

House

Referred to Rules Committee

Feb 07, 2024

House

Filed with the Clerk by Rep. Jenn Ladisch Douglass

Bill Text

Bill Text Versions Format
Introduced HTML PDF
House Amendment 001 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.